Corteva Inc (CTVA)
Official siteBASIC MATERIALS • AGRICULTURAL INPUTS • NYSE
Market Cap: $6.29B
Last updated: Nov 17, 2026 at 11:05 AM ET
Corteva Inc (CTVA) Earnings: Report Dates and Results
Corteva (CTVA) is expected to report earnings on Feb 1, 2027. In the quarter ended Sep 30, 2026, Corteva reported EPS of -$0.04, below the $0.09 estimate. It beat the EPS estimate in 6 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
CTVA has an expected report date of Feb 1, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 13.6% below the $0.22 reported for the quarter ended Dec 31, 2025.
CTVA Earnings Call
The latest CTVA earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 31 quarters below that had an estimate, CTVA beat 26, missed 4 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $2.46B, down 6.1% from $2.62B a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.04 | $0.09 | $0.00 - $0.18 | -144.44% | Miss | N/A | 6 | 0 up, 0 down | Nov 11, 2026 | $2.46B |
| Jun 30, 2026 | $2.30 | $2.24 | $2.18 - $2.33 | +2.68% | Beat | +4.5% | 15 | 0 up, 3 down | Jul 30, 2026 | $6.38B |
| Mar 31, 2026 | $1.50 | $1.18 | $1.09 - $1.24 | +27.12% | Beat | +32.7% | 14 | 2 up, 1 down | May 5, 2026 | $4.91B |
| Dec 31, 2025 | $0.22 | $0.22 | $0.19 - $0.28 | 0.00% | In line | -31.3% | 15 | N/A | Feb 3, 2026 | $3.91B |
| Sep 30, 2025 | -$0.23 | -$0.47 | -$0.54 - -$0.30 | +51.06% | Beat | N/A | 15 | 0 up, 5 down | Nov 4, 2025 | $2.62B |
| Jun 30, 2025 | $2.20 | $1.88 | $1.75 - $1.95 | +17.02% | Beat | +20.2% | 15 | 9 up, 2 down | Aug 6, 2025 | $6.46B |
| Mar 31, 2025 | $1.13 | $0.88 | $0.84 - $0.96 | +28.41% | Beat | +27.0% | 15 | 3 up, 2 down | May 7, 2025 | $4.42B |
| Dec 31, 2024 | $0.32 | $0.31 | $0.24 - $0.45 | +3.23% | Beat | +113.3% | 15 | 1 up, 8 down | Feb 5, 2025 | $3.98B |
| Sep 30, 2024 | -$0.49 | -$0.30 | -$0.40 - -$0.23 | -63.33% | Miss | N/A | 17 | 0 up, 0 down | Nov 6, 2024 | $2.33B |
| Jun 30, 2024 | $1.83 | $1.72 | $1.58 - $1.86 | +6.40% | Beat | +14.4% | 16 | 0 up, 1 down | Jul 31, 2024 | $6.11B |
| Mar 31, 2024 | $0.89 | $0.83 | $0.69 - $1.09 | +7.23% | Beat | -23.3% | 19 | 1 up, 0 down | May 1, 2024 | $4.49B |
| Dec 31, 2023 | $0.15 | $0.06 | -$0.03 - $0.15 | +150.00% | Beat | -6.3% | 18 | 0 up, 1 down | Jan 31, 2024 | $3.71B |
| Sep 30, 2023 | -$0.23 | -$0.26 | -$0.42 - -$0.07 | +11.54% | Beat | N/A | 18 | 2 up, 0 down | Nov 8, 2023 | $2.59B |
| Jun 30, 2023 | $1.60 | $1.58 | N/A | +1.27% | Beat | -2.4% | 19 | 1 up, 1 down | Aug 3, 2023 | $6.04B |
| Mar 31, 2023 | $1.16 | $0.93 | $0.83 - $1.02 | +24.73% | Beat | +19.6% | 19 | 2 up, 0 down | May 3, 2023 | $4.88B |
| Dec 31, 2022 | $0.16 | $0.06 | -$0.02 - $0.09 | +166.67% | Beat | +100.0% | 19 | 0 up, 1 down | Feb 1, 2023 | $3.83B |
| Sep 30, 2022 | -$0.12 | -$0.22 | -$0.30 - -$0.16 | +45.45% | Beat | N/A | 17 | 0 up, 0 down | Nov 3, 2022 | $2.78B |
| Jun 30, 2022 | $1.64 | $1.46 | $1.40 - $1.58 | +12.33% | Beat | +17.1% | 18 | 2 up, 0 down | Aug 4, 2022 | $6.25B |
| Mar 31, 2022 | $0.97 | $0.81 | $0.72 - $0.89 | +19.75% | Beat | +22.8% | 16 | 1 up, 1 down | May 4, 2022 | $4.60B |
| Dec 31, 2021 | $0.08 | $0.09 | $0.01 - $0.18 | -11.11% | Miss | +100.0% | 17 | 1 up, 1 down | Feb 2, 2022 | $3.48B |
| Sep 30, 2021 | -$0.14 | -$0.31 | -$0.35 - -$0.26 | +54.84% | Beat | N/A | 17 | N/A | Nov 3, 2021 | $2.37B |
| Jun 30, 2021 | $1.40 | $1.27 | $1.19 - $1.41 | +10.24% | Beat | +11.1% | 18 | N/A | Aug 5, 2021 | $5.63B |
| Mar 31, 2021 | $0.79 | $0.65 | $0.54 - $0.75 | +21.54% | Beat | +33.9% | 18 | N/A | May 4, 2021 | $4.18B |
| Dec 31, 2020 | $0.04 | -$0.04 | -$0.12 - $0.04 | +200.00% | Beat | -42.9% | 18 | N/A | Feb 3, 2021 | $3.21B |
| Sep 30, 2020 | -$0.39 | -$0.42 | -$0.50 - -$0.30 | +7.14% | Beat | N/A | 19 | N/A | Nov 4, 2020 | $1.86B |
| Jun 30, 2020 | $1.26 | $1.24 | $0.98 - $1.46 | +1.61% | Beat | -11.3% | 20 | N/A | Aug 5, 2020 | $5.19B |
| Mar 31, 2020 | $0.59 | $0.39 | $0.32 - $0.48 | +51.28% | Beat | +78.8% | 20 | N/A | May 6, 2020 | $3.96B |
| Dec 31, 2019 | $0.07 | -$0.12 | -$0.14 - -$0.09 | +158.33% | Beat | N/A | 19 | N/A | Jan 30, 2020 | N/A |
| Sep 30, 2019 | -$0.39 | -$0.45 | -$0.55 - -$0.35 | +13.33% | Beat | -135.5% | 18 | N/A | Oct 31, 2019 | $1.91B |
| Jun 30, 2019 | $1.42 | $1.02 | $0.45 - $1.37 | +39.22% | Beat | N/A | 19 | N/A | Aug 1, 2019 | $5.56B |
| Mar 31, 2019 | $0.33 | $0.35 | N/A | -5.71% | Miss | N/A | 1 | N/A | May 31, 2019 | $6.79B |
| Dec 31, 2018 | -$0.15 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 19, 2019 | N/A |
| Sep 30, 2018 | $1.10 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Oct 18, 2018 | $3.89B |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $3.32, up 30.2% from the year before. It was $0.95 for the year ended Dec 31, 2018, the oldest of the 8 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $3.32 | +30.2% |
| Dec 31, 2024 | $2.55 | -4.9% |
| Dec 31, 2023 | $2.68 | N/A |
| Dec 31, 2022 | $2.65 | +24.4% |
| Dec 31, 2021 | $2.13 | +42.0% |
| Dec 31, 2020 | $1.50 | +4.9% |
| Dec 31, 2019 | $1.43 | +50.0% |
| Dec 31, 2018 | $0.95 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 9,200 words across 19 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 9,235 | 19 | |
| 2026Q2 | Jun 30, 2026 | 7,006 | 19 | |
| 2026Q1 | Mar 31, 2026 | 8,450 | 19 | |
| 2025Q4 | Dec 31, 2025 | 8,450 | 22 | |
| 2025Q3 | Sep 30, 2025 | 8,840 | 22 | |
| 2025Q2 | Jun 30, 2025 | 8,024 | 19 | |
| 2025Q1 | Mar 31, 2025 | 4,682 | 15 | |
| 2024Q4 | Dec 31, 2024 | 8,571 | 21 |
2026Q3 Earnings Call
Opening remarks
Rafael Soares Head of Investor Relations Good morning, and welcome to Corteva's Third Quarter 2026 Earnings Conference Call. Our prepared remarks today will be led by Luke Kissam, Chief Executive Officer, and Jeff Rudolph, Chief Financial Officer. We have prepared presentation slides to supplement our remarks during this call, which are posted on the Investor Relations section of the Corteva website and through the link to our webcast. During this call, we'll make forward-looking statements, which are our expectations about the future. These statements are based upon current expectations and assumptions that are subject to various risks and uncertainties. Our actual results could materially differ from these statements due to these risks and uncertainties, including, but not limited to, those discussed on this call and in the Risk Factors section of our reports filed with the SEC. We do not undertake any duty to update any forward-looking statements. Please note, in today's presentation, we will be making reference to certain non-GAAP financial measures. EBITDA means adjusted pro forma operating EBITDA, and sales refers to pro forma net sales. Reconciliations of the non-GAAP measures can be found in our earnings press release and related schedules, along with our supplemental financial summary slide deck available on our Investor Relations website. It's now my pleasure to turn the call over to Luke.
Luke Kissam CEO Thanks, Rafa, and good morning, everybody. Thanks for joining us. This is our first earnings call as a stand-alone company. So I want to start with the strategy we laid out at our recent Investor Day and how it played out in the quarter. In September, we said this chapter would be defined by innovation and execution. This quarter gave us clear proof points on both. The exception to that is Brazil, which I will unpack a bit more in a moment. Starting with innovation. New product volumes grew 20% in the quarter with growth in every region, and price was relatively stable for this group of products. Our business outside of Latin America performed roughly in line with expectations in a challenged operating environment. We generated growth across North America, EMEA and Asia Pacific. While pricing was down 12% in North America in the quarter, all of that headwind was caused by pricing actions related to acetochlor, which we forewarned at Investor Day. Productivity came in ahead of our expectations in the quarter, and we are on track to deliver our target for the year. We also brought SG&A spending down in the quarter as teams exercised good discipline on spend relative to our operating environment. And even as we took cost out, we increased our investment in R&D to keep advancing our pipeline, which is one of the real strengths of this company.
Frequently Asked Questions About CTVA
When is Corteva's next earnings date?
Corteva's next earnings report is expected for Feb 1, 2027.
Did CTVA beat earnings estimates last quarter?
No. Corteva reported EPS of -$0.04 for the quarter ended Sep 30, 2026, below the $0.09 estimate by 144.44%.
What EPS do analysts expect from CTVA next quarter?
The consensus EPS estimate for Corteva for the quarter ending Dec 31, 2026 is $0.19 from 19 analysts, with estimates from $0.03 to $0.30.
How often does CTVA beat earnings estimates?
Corteva beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of -1.87%.
CTVA pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors